FDA Drug Application (020989) for EVOXAC by DAIICHI SANKYO

Back to FDA Applications sponsored by DAIICHI SANKYO

Application Number020989
Product Number002
FormCAPSULE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEVOXAC
Active IngredientCEVIMELINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CEVIMELINE HYDROCHLORIDE3


Back to FDA Applications sponsored by DAIICHI SANKYO